Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immune Cell Surface Receptor Cluster (CD14, LRP1, TLR4, CXCR4, HSPGs) (N/A)
- Target
- N/A
- Molecular classification
- Co-receptor, Pattern Recognition Receptor, Chemokine Receptor, Proteoglycan, Endocytic Receptor, Transmembrane protein, Glycoprotein
01
Overview
This target represents a group of interconnected immune cell surface receptors including CD14, LRP1, TLR4, CXCR4, and heparan sulfate proteoglycans (HSPGs). These molecules play critical roles in pathogen recognition, signal transduction, cellular communication, and regulation of innate and adaptive immune responses. They are involved in various diseases including infectious, autoimmune, inflammatory, and neurodegenerative diseases, making them potential therapeutic targets. Targeting this cluster requires careful consideration of potential safety concerns related to immune modulation and off-target effects.
- Other names
- CD14/TLR4/CXCR4/LRP1/HSPG complexInnate Immunity Receptor ClusterInflammatory Signaling Hub
02
Mechanism of action
Varies depending on the specific receptor and drug. Includes receptor blockade, inhibition of downstream signaling pathways (e.g., NF-κB), interference with ligand binding, and modulation of receptor trafficking.
03
Biological functions
Pathogen RecognitionSignal TransductionImmune ResponseInflammationLeukocyte TraffickingCellular CommunicationEndocytosisLipid MetabolismBlood-Brain Barrier Regulation
04
Disease associations
Infectious DiseaseAutoimmune DiseaseInflammatory DiseaseNeurodegenerative DiseaseCancerMetabolic Disorders
05
Safety considerations
ImmunosuppressionIncreased risk of infectionCytokine stormOff-target effects on other cell typesAltered leukocyte traffickingPotential for exacerbating autoimmune reactions
06
Interacting drugs
LPS
8 more in the full profile.
07
Biomarkers
CD14 expression levels in monocytesTLR4 expression levels in immune cellsCXCR4 expression levels in leukocytesSDF-1/CXCL12 levelsHSPG expression and sulfation patternsLRP1 levels in plasma/tissuesCytokine levels (e.g., TNFα, IL-1β)Soluble CD14
Beyond the preview
Go deeper on Immune Cell Surface Receptor Cluster (CD14, LRP1, TLR4, CXCR4, HSPGs) (N/A).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Immune Cell Surface Receptor Cluster (CD14, LRP1, TLR4, CXCR4, HSPGs) (N/A).